Detecting viral contaminants in biologic-based medicines-and identifying their source-requires a holistic testing approach.
Richard Adair
Advertisement
Richard Adair is virology and technical support manager, SGS Life Sciences, Glasgow, Scotland.
Articles by Richard Adair
Advertisement
Latest Updated Articles
Control Viral Contaminants with Effective TestingPublished: October 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
Establishing Risk Assessments for AI in Bio-Manufacturing
5
